Cytosorbents Corp
NASDAQ:CTSO

Watchlist Manager
Cytosorbents Corp Logo
Cytosorbents Corp
NASDAQ:CTSO
Watchlist
Price: 0.6303 USD -6.09% Market Closed
Market Cap: $39.6m

Balance Sheet

Balance Sheet Decomposition
Cytosorbents Corp

Balance Sheet
Cytosorbents Corp

Rotate your device to view
Balance Sheet
Currency: USD
May-2004 May-2005 Dec-2006 Dec-2007 Dec-2008 Dec-2009 Dec-2010 Dec-2011 Dec-2012 Dec-2013 Dec-2014 Dec-2015 Dec-2016 Dec-2017 Dec-2018 Dec-2019 Dec-2020 Dec-2021 Dec-2022 Dec-2023 Dec-2024
Assets
Cash & Cash Equivalents
0
0
3
0
3
2
1
1
2
2
4
5
5
17
22
12
71
52
22
14
3
Cash Equivalents
0
0
3
0
3
2
1
1
2
2
4
5
5
17
22
12
71
52
22
14
3
Short-Term Investments
0
0
0
0
0
0
0
0
0
0
2
2
0
0
0
0
0
0
0
0
0
Total Receivables
0
0
0
0
0
0
0
0
0
0
1
1
1
2
4
4
5
5
6
6
7
Accounts Receivables
0
0
0
0
0
0
0
0
0
0
1
1
1
2
4
4
5
5
6
6
7
Other Receivables
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Inventory
0
0
0
0
0
0
0
0
1
0
1
1
1
1
1
2
3
5
3
3
3
Other Current Assets
0
0
0
0
0
0
0
0
0
1
1
1
0
0
1
2
3
3
2
2
8
Total Current Assets
0
0
3
0
3
2
1
2
3
3
8
10
8
21
28
21
82
64
34
25
22
PP&E Net
0
0
0
0
0
0
0
0
0
0
0
1
1
1
3
3
3
19
23
22
21
PP&E Gross
0
0
0
0
0
0
0
0
0
0
0
1
1
1
0
3
3
19
23
22
21
Accumulated Depreciation
0
0
2
2
2
2
2
2
2
2
2
3
3
3
0
4
4
5
2
3
4
Intangible Assets
0
0
0
0
0
0
0
0
0
0
1
1
1
2
0
3
4
5
4
4
4
Other Long-Term Assets
0
0
0
0
0
0
0
0
0
0
0
0
0
0
3
0
0
2
2
2
2
Total Assets
0
N/A
0
-40%
3
+11 400%
1
-77%
3
+324%
2
-34%
2
-19%
2
+17%
3
+58%
4
+21%
8
+109%
11
+33%
10
-14%
24
+149%
34
+42%
27
-20%
90
+229%
90
0%
63
-29%
53
-16%
47
-11%
Liabilities
Accounts Payable
0
0
1
1
1
1
1
1
1
1
1
1
1
1
1
2
2
3
2
4
3
Accrued Liabilities
0
0
0
0
0
0
0
1
0
0
1
1
2
3
5
6
8
6
5
5
5
Short-Term Debt
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Current Portion of Long-Term Debt
0
0
0
0
0
0
0
0
1
2
0
0
1
4
1
2
0
0
0
3
0
Other Current Liabilities
0
0
0
0
0
0
0
0
0
0
3
2
0
0
0
0
0
4
3
3
1
Total Current Liabilities
0
0
1
1
1
1
1
2
2
3
5
3
4
8
7
10
10
14
10
14
10
Long-Term Debt
0
0
0
0
0
0
1
0
0
0
0
0
4
6
9
13
0
0
5
3
14
Other Liabilities
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1
1
1
13
13
13
12
Total Liabilities
0
N/A
0
+200%
1
+1 100%
1
-16%
1
+13%
1
-6%
2
+137%
2
-22%
2
+16%
3
+47%
5
+47%
3
-33%
8
+175%
14
+66%
17
+25%
24
+39%
11
-55%
27
+151%
28
+3%
29
+6%
36
+23%
Equity
Common Stock
0
0
0
0
0
0
0
0
13
16
0
0
0
0
0
0
0
0
0
0
0
Retained Earnings
0
0
67
72
75
79
84
93
99
106
124
133
144
152
170
189
197
221
254
283
304
Additional Paid In Capital
0
0
70
71
78
80
83
93
87
91
128
140
144
163
186
192
278
283
287
306
311
Other Equity
0
0
0
0
0
0
0
0
0
0
0
1
1
0
0
1
2
1
2
1
4
Total Equity
0
N/A
0
N/A
2
N/A
0
N/A
2
N/A
1
-46%
0
N/A
0
N/A
1
+294%
1
-22%
4
+304%
8
+107%
1
-84%
10
+666%
17
+65%
3
-80%
79
+2 216%
63
-21%
35
-43%
23
-34%
11
-53%
Total Liabilities & Equity
0
N/A
0
-40%
3
+11 400%
1
-77%
3
+324%
2
-34%
2
-19%
2
+17%
3
+58%
4
+21%
8
+109%
11
+33%
10
-14%
24
+149%
34
+42%
27
-20%
90
+229%
90
0%
63
-29%
53
-16%
47
-11%
Shares Outstanding
Common Shares Outstanding
0
0
1
1
1
3
5
7
9
10
23
25
25
29
32
33
43
43
44
54
55
Preferred Shares Outstanding
0
0
7
8
9
6
6
2
2
2
0
0
0
0
0
0
0
0
0
0
0